KARLEE DAVIS: Open Payments
NPI 1609476480 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$606 in 35 payments from 9 companies in 2025. Trend: 2023 $349 · 2024 $486 · 2025 $606
Food & beverage: $606
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $174 |
| GlaxoSmithKline, LLC. | 16 | $161 |
| PFIZER INC. | 5 | $100 |
| Exact Sciences Corporation | 3 | $53 |
| Novo Nordisk Inc | 2 | $33 |
| ABBVIE INC. | 1 | $22 |
| Abbott Laboratories | 1 | $21 |
| Corcept Therapeutics | 1 | $21 |
| Boston Scientific Corporation | 1 | $21 |
Products named: FARXIGA, TRELEGY ELLIPTA, PREVNAR 20, Cologuard Collection Kit, BREZTRI, SHINGRIX, QULIPTA, FREESTYLE LIBRE 3.
Industry payments across OK — which companies pay providers there.
